Intrepid Family Office’s Organogenesis Holdings ORGO Stock Holding History

Intrepid Family Office’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Sell	45,350 -28,230	-38%	-$69K	0.08%	35
2026 Q1	$174K	Sell	73,580 -26,420	-26%	-$91.5K	0.14%	34
2025 Q4	$518K	Buy	100,000 +19,900	+25%	+$96.4K	0.45%	31
2025 Q3	$338K	Sell	80,100 -29,900	-27%	-$139K	0.28%	30
2025 Q2	$403K	Buy	110,000 +10,000	+10%	+$37.3K	0.33%	33
2025 Q1	$432K	Sell	100,000 -5,000	-5%	-$20.2K	0.61%	26
2024 Q4	$336K	Buy	+105,000	New	+$352K	0.35%	29
2023 Q3	$318K	Sell	100,000 -10,000	-9%	-$31.8K	0.51%	26
2023 Q2	$365K	Buy	110,000 +70,000	+175%	+$207K	0.7%	24
2023 Q1	$85.2K	Hold	40,000	–	–	0.19%	23
2022 Q4	$108K	Buy	40,000 +5,000	+14%	+$14.6K	0.27%	22
2022 Q3	$113K	Buy	+35,000	New	+$158K	0.34%	19

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Intrepid Family Office's ORGO Position: Q2 2026 in Review

Intrepid Family Office reduced its Organogenesis Holdings (ORGO) stake by 38% in Q2 2026, selling an estimated $69K and leaving 45,350 shares worth $110K. The position accounts for 0.08% of the portfolio, ranked #35.

Intrepid Family Office first reported a position in ORGO in Q3 2022 and has held it in 12 quarters since. The position peaked at $518K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Intrepid Family Office held 45,350 shares of Organogenesis Holdings worth $110K as of Q2 2026.
Intrepid Family Office sold 28,230 Organogenesis Holdings shares in Q2 2026, an estimated $69K.
Organogenesis Holdings made up 0.08% of Intrepid Family Office's portfolio in Q2 2026, its #35 holding.
Intrepid Family Office first reported a position in Organogenesis Holdings in Q3 2022 and has held it in 12 quarters since.
Intrepid Family Office's Organogenesis Holdings position peaked at $518K in Q4 2025.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Intrepid Family Office's 13F filing for Q2 2026, filed 14 Aug 2026.